Status:
WITHDRAWN
Adaptive Behavior Assessment of Men With 49, XXXXY, Klinefelter Syndrome
Lead Sponsor:
University of Wisconsin, Madison
Collaborating Sponsors:
Solvay Pharmaceuticals
Conditions:
Klinefelter Syndrome
Eligibility:
MALE
2-21 years
Brief Summary
Klinefelter syndrome, a congenital chromosomal abnormality with one or more extra X chromosomes, occurs in out of 400 live male births. The majority of Klinefelter men present with a 47, XXY karyotype...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Any Klinefelter male with proven 49,XXXXY karyotype, who does not present with and is not being treated for significant physical/mental illness which might affect his adaptive behavior, who or whose parent or primary caretaker is able to provide informed consent to participate in the study and who or whose parent or primary caretaker has adequate command of the English language, to provide meaningful information will be invited to participate in this study.
Exclusion
Key Trial Info
Start Date :
June 1 2006
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 1 2008
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00347464
Start Date
June 1 2006
End Date
August 1 2008
Last Update
December 3 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Wisconsin School of Medicine and Public Health
Madison, Wisconsin, United States, 53792